Intermittent X-linked thrombocytopenia with a novel WAS gene mutation.

Article Details

Citation

Wada T, Itoh M, Maeba H, Toma T, Niida Y, Saikawa Y, Yachie A

Intermittent X-linked thrombocytopenia with a novel WAS gene mutation.

Pediatr Blood Cancer. 2014 Apr;61(4):746-8. doi: 10.1002/pbc.24787. Epub 2013 Sep 21.

PubMed ID
24115682 [ View in PubMed
]
Abstract

X-linked thrombocytopenia (XLT) is caused by mutations in the WAS gene and characterized by thrombocytopenia with minimal or no immunodeficiency. Patients with XLT usually exhibit persistent thrombocytopenia, and intermittent thrombocytopenia has been described only in two families. Here, we report a patient with intermittent XLT carrying a novel missense mutation (Ala56Thr). He showed residual expression of Wiskott-Aldrich syndrome protein in the lymphocytes and platelets. There appeared to be an association between normal platelet numbers and a post infectious state. Our findings further support the importance of analysis of Wiskott-Aldrich syndrome protein in male patients who exhibit fluctuating courses of thrombocytopenia.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Wiskott-Aldrich syndrome proteinP42768Details